Selected article for: "life quality and survival time"

Author: DOKI, Tomoyoshi; TAKANO, Tomomi; HOHDATSU, Tsutomu
Title: Development of a mouse-feline chimeric antibody against feline tumor necrosis factor-alpha
  • Document date: 2016_6_4
  • ID: y0x0quha_25
    Snippet: FIP is a fatal inflammatory disease caused by FIPV. Treatment of FIP-induced systemic inflammation with antiinflammatory drugs, such as steroids, has been investigated, but existing anti-inflammatory drugs only transiently improves FIP symptoms, and the survival time and quality of life remain unable to be improved [6] . We previously reported that progression to the FIP was prevented by inhibition of the physiological activity of an inflammatory.....
    Document: FIP is a fatal inflammatory disease caused by FIPV. Treatment of FIP-induced systemic inflammation with antiinflammatory drugs, such as steroids, has been investigated, but existing anti-inflammatory drugs only transiently improves FIP symptoms, and the survival time and quality of life remain unable to be improved [6] . We previously reported that progression to the FIP was prevented by inhibition of the physiological activity of an inflammatory cytokine, TNF-alpha. When anti-fTNF-alpha mouse mAb was administered to cats with FIP, their survival time and quality of life were improved [3] . However, administration of mouse mAb to xenogeneic animals may cause adverse reactions. We prepared mouse-feline chimeric mAb (chimeric mAb 2-4) by modifying the mouse anti-fTNF-alpha mAb 2-4 and investigated its fTNF-alpha neutralization activity. In addition, changes in the feline anti-mouse antibody response-inducing ability induced by repeated administration of purified mouse mAb 2-4 and chimeric mAb 2-4 in cats were investigated.

    Search related documents:
    Co phrase search for related documents
    • anti ftnf alpha and FIP cat: 1
    • anti ftnf alpha and FIP progression: 1
    • anti ftnf alpha and ftnf alpha: 1, 2, 3, 4, 5, 6, 7, 8
    • anti ftnf alpha and ftnf alpha neutralization activity: 1, 2, 3, 4
    • anti inflammatory drug and ftnf alpha: 1
    • anti inflammatory drug and inflammatory cytokine: 1, 2, 3, 4, 5, 6
    • FIP cat and FIPV cause: 1, 2
    • FIP cat and ftnf alpha: 1, 2
    • FIP progression and ftnf alpha: 1